| 7202 | A | 079150 | 002 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | AUROBINDO PHARMA LTD | 200MG/5ML | AB | ["AB"] | 2009-09-18 | Sep 18, 2009 | No | No | No | RX | AUROBINDO PHARMA LTD | 5c072f02951b050144bcea025170533e5b6f6cc0fd7451843e287ef1d30be90a |
| 7203 | A | 076246 | 001 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | HIKMA | 50MG/5ML | | [] | 2004-07-29 | Jul 29, 2004 | No | No | No | DISCN | HIKMA PHARMACEUTICALS USA INC | 56a2575471afb557ff8c71f120197f4a4ac330a3a9da4a18352834cfa48efd18 |
| 7204 | A | 076246 | 002 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | HIKMA | 200MG/5ML | | [] | 2004-07-29 | Jul 29, 2004 | No | No | No | DISCN | HIKMA PHARMACEUTICALS USA INC | f36272a2c284a3f2ce0bf2a524faacde4c31e924eadded951175a248d82b4c99 |
| 7205 | A | 077523 | 001 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | IVAX SUB TEVA PHARMS | 50MG/5ML | | [] | 2007-09-12 | Sep 12, 2007 | No | No | No | DISCN | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA | 18e92321ca10243b6695f0409010acb546162b6aadc20e815272ac92e1934d82 |
| 7206 | A | 077523 | 002 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | IVAX SUB TEVA PHARMS | 200MG/5ML | | [] | 2007-09-12 | Sep 12, 2007 | No | No | No | DISCN | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA | 3e492e9aa1e579c30cda3ecdab2abffc9a16548b21b9da3c351cdfe249392aeb |
| 7207 | A | 076332 | 001 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | SUN PHARM INDS LTD | 50MG/5ML | | [] | 2004-07-29 | Jul 29, 2004 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | 882e7ee70012c1d5bac667b8839010107eb7bf792cb6fc73cdf57815e4a048c7 |
| 7208 | A | 076332 | 002 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | SUN PHARM INDS LTD | 200MG/5ML | | [] | 2004-07-29 | Jul 29, 2004 | No | No | No | DISCN | SUN PHARMACEUTICAL INDUSTRIES LTD | 49022fcf56de7d022f81da028c91626c3cb84234206d14a794c13e4b1b6467fc |
| 7209 | A | 076918 | 001 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | TARO PHARM INDS | 50MG/5ML | | [] | 2006-12-18 | Dec 18, 2006 | No | No | No | DISCN | TARO PHARMACEUTICAL INDUSTRIES LTD | 745f45cda6d06ad9302c2e2293a86a3ab915c326b0c34040aff75ab2e7a3e7c7 |
| 7210 | A | 076918 | 002 | FLUCONAZOLE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | FLUCONAZOLE | TARO PHARM INDS | 200MG/5ML | | [] | 2006-12-18 | Dec 18, 2006 | No | No | No | DISCN | TARO PHARMACEUTICAL INDUSTRIES LTD | 5677621d4a9cdddcb36bd497c458a2d13931e82c32af9d5b84e4062574dbe1bd |
| 7211 | A | 072319 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | GLYCOPREP | GOLDLINE | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | | [] | 1988-12-23 | Dec 23, 1988 | No | No | No | DISCN | GOLDLINE LABORATORIES INC | 93a45db8765ae86e1e13a2c0410981677486a9add76c9022a2d43af8eef2bb3a |
| 7212 | A | 073433 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | GO-EVAC | VINTAGE PHARMS | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | | [] | 1992-04-28 | Apr 28, 1992 | No | No | No | DISCN | VINTAGE PHARMACEUTICALS | 3461cbbd32d1eb66b7b7f7ca64465c503d82d242b5274d6d6b92c3ddd111dfe1 |
| 7213 | A | 061893 | 001 | ERYTHROMYCIN ESTOLATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | ILOSONE | DISTA | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | DISTA PRODUCTS CO DIV ELI LILLY AND CO | f8c83666e08cf4832283539dc466882551193cab933297945f3bc4e9fb9e71e0 |
| 7214 | N | 050406 | 003 | CEPHALEXIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | KEFLEX | PRAGMA | EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons* | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | PRAGMA PHARMACEUTICALS LLC | 12628be40ca767a80add84fd64c39f918e9a04f261a32fc25dee9d777be591a1 |
| 7215 | N | 050406 | 001 | CEPHALEXIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | KEFLEX | PRAGMA | EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | PRAGMA PHARMACEUTICALS LLC | 67a03052234ff4ce690935708fde8a49c60ece08bab9467262ec45c99580c0a4 |
| 7216 | N | 050406 | 002 | CEPHALEXIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | KEFLEX | PRAGMA | EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons* | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | PRAGMA PHARMACEUTICALS LLC | dd42d8fa54a5db69650deb86a9a53e3c4fe1a557298790d171291bcb46a4050a |
| 7217 | N | 050460 | 006 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LAROTID | GLAXOSMITHKLINE | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | GLAXOSMITHKLINE | d9f340b81c8b8b695fe108feb69b803117bc4d0112e6a6ad6fd5ed1a094377cc |
| 7218 | A | 062226 | 003 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LAROTID | NEOPHARMA | 125MG/5ML | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | NEOPHARMA INC | 65ae7bcc7a84f89b20ccde62bd9e17e2a4ac4596ba6f26660a8005a8838aa467 |
| 7219 | A | 062226 | 004 | AMOXICILLIN | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LAROTID | NEOPHARMA | 250MG/5ML | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | NEOPHARMA INC | cce44999323358c1d73afa461dacdc04020bcb427c5feef5781c561e379d9117 |
| 7220 | A | 200068 | 001 | LINEZOLID | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LINEZOLID | HIKMA | 100MG/5ML | AB | ["AB"] | 2015-06-03 | Jun 3, 2015 | No | No | No | RX | HIKMA PHARMACEUTICALS USA INC | debe92d971cc8c99ae3712170945f277bc27e48318b9119829e6112a34b8d002 |
| 7221 | N | 207078 | 001 | SODIUM ZIRCONIUM CYCLOSILICATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LOKELMA | ASTRAZENECA | 5GM/PACKET | | [] | 2018-05-18 | May 18, 2018 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | 90ea6de6c01d6b4572a6f409f4a00d19696167d214d7e2fd0dc500c5c9c2f71f |
| 7222 | N | 207078 | 002 | SODIUM ZIRCONIUM CYCLOSILICATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LOKELMA | ASTRAZENECA | 10GM/PACKET | | [] | 2018-05-18 | May 18, 2018 | No | Yes | Yes | RX | ASTRAZENECA PHARMACEUTICALS LP | a95b3486c1d60474129ef8f84e947674a3332023d17d15009bebe4255de2ede0 |
| 7223 | N | 050667 | 001 | LORACARBEF | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LORABID | KING PHARMS | 100MG/5ML | | [] | 1991-12-31 | Dec 31, 1991 | No | No | No | DISCN | KING PHARMACEUTICALS INC | fab48de851534fd3420b6c89a03676ba9d52346933abeeddd6faa474b11da3ba |
| 7224 | N | 050667 | 002 | LORACARBEF | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | LORABID | KING PHARMS | 200MG/5ML | | [] | 1991-12-31 | Dec 31, 1991 | No | No | No | DISCN | KING PHARMACEUTICALS INC | a70f6c19557daf7fd1b8ca287e32e058ca284b866d5534bf1c43aa5db3bfdf22 |
| 7225 | A | 205545 | 001 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMEPRAZOLE AND SODIUM BICARBONATE | AJANTA PHARMA LTD | 20MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2016-07-27 | Jul 27, 2016 | No | No | No | RX | AJANTA PHARMA LTD | bbc413715eaa56708dc6532cc9f8dcbb8bc0fd946a2b47f9eecb14023e691fb7 |
| 7226 | A | 205545 | 002 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMEPRAZOLE AND SODIUM BICARBONATE | AJANTA PHARMA LTD | 40MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2016-07-27 | Jul 27, 2016 | No | No | No | RX | AJANTA PHARMA LTD | 12165b0a6a133cf3d5f417c37c059cab09355ec87c37ed32471f1f5e586ae45d |
| 7227 | A | 079182 | 001 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMEPRAZOLE AND SODIUM BICARBONATE | PAR PHARM | 20MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2013-04-19 | Apr 19, 2013 | No | No | No | RX | PAR PHARMACEUTICAL INC | eed7f15a8c4418268cb14c26b3c435a554c6765217c71d742b51a8cbdb7f3c5f |
| 7228 | A | 079182 | 002 | OMEPRAZOLE; SODIUM BICARBONATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMEPRAZOLE AND SODIUM BICARBONATE | PAR PHARM | 40MG/PACKET;1.68GM/PACKET | AB | ["AB"] | 2013-04-19 | Apr 19, 2013 | No | No | No | RX | PAR PHARMACEUTICAL INC | 0877b63dc42eb2ab456637e96ccbabc47f5ff8c3e77fbd7a34210acd50bbece8 |
| 7229 | N | 050749 | 001 | CEFDINIR | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNICEF | ABBVIE | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1997-12-04 | Dec 4, 1997 | No | Yes | No | DISCN | ABBVIE INC | 23b02ea2867aa78e07fec2b900ac8dc49129f2f58ce04d876f57262e9649c147 |
| 7230 | N | 050749 | 002 | CEFDINIR | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNICEF | ABBVIE | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2004-07-29 | Jul 29, 2004 | No | Yes | No | DISCN | ABBVIE INC | 3dc796fa1e4679b8d78f75e962626f6e1af5e138fef38c9f9052415428e6a381 |
| 7231 | A | 060625 | 001 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNIPEN (AMPICILLIN) | WYETH AYERST | 100MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 7b44535a69ef28143b6e6d1727bd92d1a30004700040cb449fe40ab9dc6b539a |
| 7232 | A | 060625 | 002 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNIPEN (AMPICILLIN) | WYETH AYERST | 125MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 6701e7630ddc2185b5d2df58d14a740e030944cee2e617d2550f9fb67a374451 |
| 7233 | A | 060625 | 003 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNIPEN (AMPICILLIN) | WYETH AYERST | 250MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 01ddfb35b3a2ab32dc1f0a8d44a3fe703bbb27e434f12f44cfcfe9075289d943 |
| 7234 | A | 060625 | 004 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OMNIPEN (AMPICILLIN) | WYETH AYERST | 500MG/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 977ffc8fdfa3c68a0ba885e42edd9fd8bdd00b24149e9a5cb05c7a92c4ecab5a |
| 7235 | A | 212784 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | AJANTA PHARMA LTD | EQ 6MG BASE/ML | AB | ["AB"] | 2020-05-27 | May 27, 2020 | No | No | No | RX | AJANTA PHARMA LTD | 09c5ea6b7d1d2ffe658ff9f59ceadf5aeb3c23c36b6c9a4a0f7b1ed4ee7de6f4 |
| 7236 | A | 208823 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | ALVOGEN PINE BROOK | EQ 6MG BASE/ML | AB | ["AB"] | 2017-10-31 | Oct 31, 2017 | No | No | No | RX | ALVOGEN PINE BROOK LLC | 0827318ea2ac56a8b9049d1f0e729bc6ae27b26d1f2f8116faa5f4321f4cc3b0 |
| 7237 | A | 210186 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | AMNEAL PHARMS NY | EQ 6MG BASE/ML | AB | ["AB"] | 2018-02-27 | Feb 27, 2018 | No | No | No | RX | AMNEAL PHARMACEUTICALS OF NY LLC | 916315610e5103dcec8f0585eae9b82f09e035801bb0c7b63e196a506405b624 |
| 7238 | A | 208347 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | LUPIN | EQ 6MG BASE/ML | AB | ["AB"] | 2018-02-20 | Feb 20, 2018 | No | No | No | RX | LUPIN INC | f21f90dab2a4d967e1dd84f8e1a4e77a49cc8790ed431d783ad8381f89b49c87 |
| 7239 | A | 209113 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | NESHER PHARMS | EQ 6MG BASE/ML | AB | ["AB"] | 2017-09-14 | Sep 14, 2017 | No | No | No | RX | NESHER PHARMACEUTICALS USA LLC | def4f7ddde6e08905b4b9f61beb406bcd31dec388333e84ca6a688328a8697dc |
| 7240 | A | 211125 | 001 | OSELTAMIVIR PHOSPHATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | OSELTAMIVIR PHOSPHATE | TEVA PHARMS USA | EQ 6MG BASE/ML | AB | ["AB"] | 2019-02-27 | Feb 27, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 6b76c56243339d3e04fcfae57a0b292d0561234c88e57c059475f0fbcb25a33c |
| 7241 | N | 050092 | 001 | DICLOXACILLIN SODIUM | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PATHOCIL | WYETH AYERST | EQ 62.5MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 5315d4e834b3dbd16d7818f7272807e849bec3f760a968a6a9c746baaab18e29 |
| 7242 | A | 073098 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PEG-LYTE | SANDOZ | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | | [] | 1993-08-31 | Aug 31, 1993 | No | No | No | DISCN | SANDOZ INC | 4c9e2700ab87f8faec0dfa5253b0bca5529fc50f93765013f01b98b5f7567d04 |
| 7243 | N | 050019 | 001 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PENBRITIN | WYETH AYERST | EQ 100MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | bd4870466b6dac4fcc3a7a0cefd15ea74f38403cfd2bf81a8c22328fa58cdad4 |
| 7244 | N | 050019 | 002 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PENBRITIN | WYETH AYERST | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 9b91a4bc9a0012fd2e313b9dd16d24c73135ec331dfa2ef5f4636f3a3643a9fc |
| 7245 | N | 050019 | 003 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PENBRITIN | WYETH AYERST | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | cf94adbd045abc64906cc73faa030de1f5d91c0a515fed0378a083327c29ecac |
| 7246 | N | 019527 | 001 | FAMOTIDINE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PEPCID | SALIX PHARMS | 40MG/5ML | | [] | 1987-02-02 | Feb 2, 1987 | No | Yes | No | DISCN | SALIX PHARMACEUTICALS INC | 691286b20e11b81bc5d9bb9381fa7e42fbc29e313b8c8887e15033e56e1051f8 |
| 7247 | A | 062049 | 001 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PFIZERPEN-A | PFIZER | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER LABORATORIES DIV PFIZER INC | 5e033eb55658affe4e01e702db8be251f9412f991b56f49dccb46d7e05b816ab |
| 7248 | A | 062049 | 002 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | PFIZERPEN-A | PFIZER | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER LABORATORIES DIV PFIZER INC | 481cb55c5e9351db0275bd607076d4987ee88d1b101175bb475805d943f93cd3 |
| 7249 | A | 062297 | 001 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | POLYCILLIN | APOTHECON | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 4699b288a64ff845a9881d14aba3b285e8a076983340b00c0fcb94245288271b |
| 7250 | A | 062297 | 002 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | POLYCILLIN | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | b257c0f077a0367674881a9001ddd7f39315d5ad19da68dc895aa124abd3e823 |
| 7251 | N | 050308 | 004 | AMPICILLIN/AMPICILLIN TRIHYDRATE | FOR SUSPENSION;ORAL | FOR SUSPENSION | ORAL | POLYCILLIN | BRISTOL | EQ 100MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO | b6b2f48354e668051bccd8355bad3ac785d921f5298163588c3593cc03a7cce6 |